PHOENIX, Feb. 06, 2018 — GB Sciences, Inc. (OTCQB:GBLX) (the â€œcompanyâ€�), discusses 2017 achievements and 2018 operations expectations, on Stock Day Podcast with Everett Jolly.
â€œIt is great to have GB Sciences Inc. back on the show,â€� said Jolly. â€œThe stock has done tremendously in recent months and monthly revenues are increasing.â€�GB Sciences Inc., is a science oriented cannabis company working with top scientist in the industry to develop evidence based compounds to treat specific diseases. The companyâ€™s growth strategy, based on three areas of focus, has allowed GB Science to develop recurring revenue streams, grow geographically, and make progress scientifically.John Poss commented, â€œWe are thrilled to be making strides to help patients who suffer from multiple diseases. We are using our work in biotech and genetics to propagate specific strains of cannabis that we believe will target conditions like Parkinsonâ€™s and heart disease.â€�The company currently holds multiple provisional patents and will embark on patient trials in the year to come.To view the interview in its entirety, click here: https://upticknewswire.com/featured-interview-ceo-john-poss-of-gb-sciences-inc-otcqb-gblx-3About GB Sciences, Inc.
GB Sciences, Inc. (GBLX) is a diverse cannabis company, focused on standardized cultivation and production methods; as well as biopharmaceutical research and development. The Companyâ€™s goal is creating safe, standardized, pharmaceutical-grade, cannabinoid therapies that target a variety of medical conditions. To learn more about GB Sciences, Inc., go to: http://gbsciences.com.Forward-Looking Statements
This press release may contain statements relating to future results or events, which are forward-looking statements. Words such as â€œexpectsâ€�, â€œintendsâ€�, â€œplansâ€�, â€œmayâ€�, â€œcouldâ€�, â€œshouldâ€�, â€œanticipatesâ€�, â€œlikelyâ€�, â€œbelievesâ€� and words of similar import may identify forward-looking statements. These statements are not historical facts, but instead represent only the Companyâ€™s belief regarding future events, many of which, by their nature, are inherently uncertain and outside of the Companyâ€™s control. It is possible that the Companyâ€™s actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in these forward-looking statements. Further, information concerning the Company and its business, including factors that potentially could materially affect the Companyâ€™s business and financial and other results, are contained in the Companyâ€™s filings with the Securities and Exchange Commission, available at www.sec.gov. All forward-looking statements included in this press release are made only as of the date of this press release, and we do not undertake any obligation to publicly update or correct any forward-looking statements to reflect events or circumstances that subsequently occur or of which we hereafter become aware.
Note: Although the Companyâ€™s research and development activities are not illegal, the production and sale of cannabis products violate federal laws as they presently exist.Contact
GB Sciences, Inc.,
1-866-721-0297, or http://gbsciences.com
Tom Arcuragi, Sr VP, [email protected]About Uptick Newswire and the â€œStock Day Podcastâ€�
Uptick Newswire is a private company reaching out to the masses keeping investors and shareholders up to date on company news and bringing transparency to the undervalued, undersold, micro-cap stocks of the market and is the sole producer of the Uptick Network â€œStock Dayâ€� Podcast. The Uptick Network â€œStock Dayâ€� Podcast is an extension of Uptick Newswire and has recently launched the Video Interview Studio located in Phoenix, Arizona with its new host Kathryn Donnelly.Follow us and keep an eye on Uptickâ€™s YouTube, Twitter, and Facebookâ€‹ for additional radio and video shows produced by Uptick! â€‹https://www.youtube.com/watch?v=kU5SVLp4orgInvestors Hangout is a proud sponsor of Stock Day and Uptick Newswire encourages listeners to visit GB Sciencesâ€™s message board on: https://investorshangout.com/GB-Sciences-Inc-GBLX-67373/
Latest posts by Maria Burns (see all)
- Dubai Moves to Honour Knowledge Pioneer With $1 Million Mohammed bin Rashid Al Maktoum Knowledge Award - May 20, 2018
- Court Dismisses Andrea Tantaros Lawsuit Against Fox News And Pete Snyder - May 20, 2018
- President Jimmy Carter spurs Liberty University Class of 2018 to success through service - May 19, 2018